Tuesday 13 October 2026 Export EDIT’s income statement to Excel — free account

Editas Medicine, Inc.

Editas Medicine, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $40.5 million, up 25.4% from fiscal 2024. In the quarter to June 2026, revenue grew 232.3%, EPS grew 76.2% and free cash flow grew 40.7%, each against the same quarter a year earlier.

2.45 0.30 −10.91%

Follow EDIT

Alert me

Market cap: $422.3M
P/E: 0.0×
Fwd P/E: −2.7×
Dividend yield: —
F-score: 2/9
Altman Z: −13.39
Beneish M: −2.46
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Older periods	Sep '25	Dec '25	Mar '26	Jun '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		6.74	4.49	6.25	8.22
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(10.14)	(5.00)	(10.48)	(13.07)
P/B ratio Full definition →		23.24	6.67	54.84	3.67
Price to Tangible BV Full definition →		23.24	6.67	54.84	3.67
EV/Sales Full definition →		3.87	1.67	3.89	4.41
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(1.00)	(0.41)	(1.07)	(1.73)
EV/FCF Full definition →		(0.99)	(0.41)	(1.07)	(1.72)
Quick Ratio Full definition →		2.81	3.50	3.17	3.13
Current Ratio Full definition →		2.86	3.54	3.22	3.19
Net Debt/EBITDA Full definition →		6.93	21.10	5.04	11.58
Debt/Assets Full definition →		0.00%	0.00%	0.00%	0.00%
Debt/Equity Full definition →		0.00	0.00	0.00	0.00
Asset Turnover Full definition →		0.18	0.15	0.19	0.21
Operating CF/Net income Full definition →		1.23	6.47	0.92	1.62
Capex/Depreciation Full definition →		(0.66)	0.07	0.13	(0.39)
Interest Coverage Full definition →		(10.23)	16.71	(23.32)	(17.49)
Research and Development Expense of Revenue Full definition →		262.16%	110.76%	621.69%	169.72%
Selling, General and Administrative Expense of Revenue Full definition →		163.28%	45.89%	361.50%	97.59%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		29.54%	8.61%	74.25%	18.44%
Graham Net Nets Full definition →		(0.04)	0.03	(0.07)	0.22
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(68.59%)	(92.20%)	(49.80%)	(23.15%)
Free Cash Flow Yield Full definition →		(57.76%)	(91.01%)	(58.18%)	(31.12%)
Revenue per Share Full definition →		0.08	0.28	0.03	0.10
Operating CF per Share Full definition →		(0.34)	(0.41)	(0.24)	(0.25)
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.35)	(0.41)	(0.23)	(0.25)
Cash per Share Full definition →		1.84	1.65	1.26	1.77
Shareholders Equity per Share Full definition →		0.15	0.31	0.05	0.88
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.15	0.31	0.05	0.88
Free Cash Flow Full definition →		(31.28)	(36.33)	(23.00)	(29.67)
Working Capital Full definition →		115.12	117.65	88.29	149.63
Capital Expenditures Full definition →		(0.43)	0.06	0.06	(0.11)
Net Current Asset Value Full definition →		(11.41)	4.65	(16.86)	85.98
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.06	0.00	(0.02)	0.01
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		4.13	15.72	1.55	1.66
Average Payables Full definition →		7.83	4.05	4.90	5.73
Average Assets Full definition →		264.66	264.06	206.50	223.97
Average Common Equity Full definition →		94.54	80.78	33.41	62.24

Fold the line items

Columns are period end dates

Stockrow Weekly